These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 6707697

  • 1. Immunobiology of primary intracranial tumors: IX. Phase I study of human lymphoblastoid interferon.
    Mahaley MS, Urso MB, Whaley RA, Staab EV, Williams TE, Guaspari A.
    J Biol Response Mod; 1984; 3(1):19-25. PubMed ID: 6707697
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effect of human lymphoblastoid interferon (MOR-22) on malignant brain tumors--a phase II study].
    Hirakawa K.
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun 20; 21(5):1068-74. PubMed ID: 3760650
    [No Abstract] [Full Text] [Related]

  • 3. Phase I study of recombinant beta-interferon given by four-hour infusion.
    Grunberg SM, Kempf RA, Venturi CL, Mitchell MS.
    Cancer Res; 1987 Feb 15; 47(4):1174-8. PubMed ID: 3802098
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 15; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of human lymphoblastoid interferon in patients with multiple myeloma.
    Cox EB, Laszlo J, Krown S, Mintzer D, Sarna G.
    J Biol Response Mod; 1988 Jun 15; 7(3):318-25. PubMed ID: 3392554
    [Abstract] [Full Text] [Related]

  • 12. Prospectively randomized toxicity study of high-dose versus low-dose treatment strategies for lymphoblastoid interferon.
    Silver HK, Connors JM, Salinas FA.
    Cancer Treat Rep; 1985 Jun 15; 69(7-8):743-50. PubMed ID: 4016785
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of betaseron (beta ser17-interferon) as treatment of advanced malignant melanoma.
    Sarna GP, Figlin RA, Pertcheck M.
    J Biol Response Mod; 1987 Aug 15; 6(4):375-8. PubMed ID: 3625229
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG, Eder JP, Ryan DP, Seiden MV, Lynch TJ, Amrein PC, Kufe DW, Clark JW.
    Clin Cancer Res; 2003 Nov 01; 9(14):5178-86. PubMed ID: 14613997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase I study of high-dose etoposide phosphate in man.
    Fields SZ, Budman DR, Young RR, Kreis W, Ingram R, Schulman P, Cherny RC, Wright J, Behr J, Snow C, Schacter LP.
    Bone Marrow Transplant; 1996 Nov 01; 18(5):851-6. PubMed ID: 8932836
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.
    Izquierdo MA, Bowman A, García M, Jodrell D, Martinez M, Pardo B, Gómez J, López-Martin JA, Jimeno J, Germá JR, Smyth JF.
    Clin Cancer Res; 2008 May 15; 14(10):3105-12. PubMed ID: 18483378
    [Abstract] [Full Text] [Related]

  • 20. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr 15; 12(4):913-20. PubMed ID: 3885862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.